Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (DEFICIT) (Details 1)

v3.10.0.1
STOCKHOLDERS' EQUITY (DEFICIT) (Details 1) - $ / shares
6 Months Ended
Sep. 30, 2018
Mar. 31, 2018
Warrants outstanding 10,261 256,448
Warrant exercise price $ 321.01 $ 12.94
Warrants - Exercise Price 69.82 [Member]    
Warrants outstanding [1] 2,667  
Warrant exercise price [1] $ 61.50  
Warrant Expiration date [1] Apr. 21, 2019  
Warrants - Exercise Price 37.50 [Member]    
Warrants outstanding [2] 4,972  
Warrant exercise price [2] $ 37.50  
Warrant Expiration date [2] Apr. 21, 2021  
Warrants - Exercise Price 6.25 [Member]    
Warrants outstanding [3] 64,000  
Warrant exercise price [3] $ 6.25  
Warrant Expiration date [3] Jun. 12, 2022  
Warrants - Exercise Price 0.39 [Member]    
Warrants outstanding [4] 1,000,000  
Warrant exercise price [4] $ 0.39  
Warrant Expiration date [4] May 24, 2023  
Warrants [Member]    
Warrants outstanding 1,071,639  
[1] Warrants issued in connection with the sale of units in the Company's unit offering in April 2014. The Warrants became exercisable on April 21, 2014 and will remain exercisable thereafter until April 21, 2019.
[2] Warrants issued in connection with the sale of convertible notes. The warrants were exercisable on the grant date (April 26, 2016) and remain exercisable until April 26, 2021.
[3] Warrants issued in connection with the Initial Tranche of the funding from Vantage. The warrants were exercisable on the grant date (June 12, 2017) and remain exercisable until June 12, 2022.
[4] Warrants issued in connection with the Severance Agreement with Richard Azar. The warrants were exercisable on the grant date (May 25, 2018) and remain exercisable until May 24, 2023.